SBIR/STTR Research Award

An Open Web Service For Fragment-based Design of Small Molecule Inhibitors

Award identifier 4c03528bd8f53b09b18afd3c354feb095a50f29e4ed026e23e7a72d6652c3a0cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,589,900

Program and phase

SBIR · Phase II

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CONIFER POINT PHARMACEUTICALS LLC
Proposal award date
2018-03-01
Contract end date
2021-02-28
UEI
RFUJM8H9JSU4
Solicitation number
PA17-302
Topic code
400

Research abstract

SignificanceConifer Point is compiling a vast array of data describing the binding of small chemical fragments to proteinsWe use an innovative Monte Carlo simulator to produce this rigorous dataand use a powerful proprietary search algorithm to mine itThis information uncovers idiosyncratic details about protein binding sites that empower medicinal chemists to design therapeutic compounds which bind in a highly specific fashion to achieve cross protein selectivitymutation avoidanceand high ligand efficiencyaffinity molecular weightOur goal is to provide chemists with affordableready access to powerfulpredictive tools specifically designed to help them generate and prioritize ideas for progressing their hit compoundsdesigns resulting in molecules that optimally bind into the protein targetFragment binding data also enables projects to get started on difficult targets where screening has limited successThis can greatly expand the number of addressable disease targetssuch as protein protein interactionsOur team has uniquely demonstrated the ability to produce fragment maps on a large scalegenerating andgtsuch maps in the last several yearsMore fragment maps enable broader searches to find more chemical possibilitiesOur long term goal is to makes of fragment maps on a fewtherapeutically important proteinsSuch a huge compilation of fragment binding data will be unprecedentedInnovationOver the last decadethe PI and participants on this grant have been employing these fragment water binding maps on dozens of successful pre clinical lead identification projectsbut they were restricted to proprietary commercial effortsOur goal now is to make the information derived from fragment maps available at low cost to a broad community of researchers in drug discoveryWe do this through a novel Web application that provides fragment based design services leveraging the latest Web technologies for browser based computation and integrates with other chemist requested capabilitiesIncluded are water maps ranked by binding free energy that are inexpensive to produceandlt $proteinyet uniquely describe multi body water configurationsComputational chemistry software is poised for a fundamental transition from desktop software to Webbased applications with low cost subscriptions and a broader audienceOur Web application represents the vanguard of this transitionSpecific AimsWe have received feedback from evaluations of our prototype fragment based chemistry design service regarding issues which have led to three specific aimsAimExpand the collection of maps to include proteins fromof the Therapeutic Target Databaseincluding a core set of fragments covering commerciallyavailable fragment compound librariesAimBuild interfaces in the Web application that enable users to define new fragmentsand run incremental fragment map simulations on existing protein structuresAimDramatically improve the performance of the computations for energy minimization to achieve immediate feedback during designOverall ImpactResearchers need alternative approaches to drug lead developmentMining fragment maps is a fertile source of new chemistry ideasWhen widely adoptedthe comprehensive Web service would provide the platform to significantly advance drug discovery Our mission is to provide easy access via the Web to a vast array of data describing the binding ofsmall chemical fragments to proteinsleveraging this data to empower medicinal chemists in addressing the corechallenges of drug discoverySpecificitypotencyand mutation avoidance of drugs require thatcompounds bind to the target protein in a way that exploits the highly idiosyncratic details of theD structure of that protein which are uncovered by the binding of the chemical fragmentsThisprovides chemists with a powerful new tool for generating ideas to resolve conflicting drugoptimization goalsand can greatly expand the number of addressable disease targetssuch asprotein protein interactionsas has been demonstrated

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2016–2025). Reported award amounts total $5,808,280. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.